Lv3
280 积分 2022-03-15 加入
Elucidating the genomic architecture of Asian EGFR-mutant lung adenocarcinoma through multi-region exome sequencing
18天前
已完结
Detection of EGFR exon 20 insertion mutations in non-small cell lung cancer: implications for consistent nomenclature in precision medicine
1个月前
已完结
Targeted Therapies for Lung Cancer Patients With Oncogenic Driver Molecular Alterations
1个月前
已完结
Real-world Comparison of P53 Immunohistochemistry and TP53 Mutation Analysis Using Next-generation Sequencing
3个月前
已完结
[Expert consensus on clinical practice of EGFR exon20 insertion detection in non-small cell lung cancer in China (2024 edition)]
1年前
已完结
MARIPOSA: phase 3 study of first-line amivantamab + lazertinib versus osimertinib in EGFR-mutant non-small-cell lung cancer
1年前
已完结
Amivantamab plus Chemotherapy in NSCLC with EGFR Exon 20 Insertions
1年前
已完结
Alectinib for treating patients with metastatic ALK-positive NSCLC: systematic review and network metanalysis
1年前
已完结
Atezolizumab + obinutuzumab + venetoclax in patients with relapsed or refractory diffuse large B-cell Lymphomas (R/R DLBCL): Primary analysis of a phase II trial from LYSA
1年前
已关闭
Clinical application of circulating tumour DNA in colorectal cancer
1年前
已完结
皖公网安备34019202002308
